Bayer to pay $7.25 billion to settle Roundup cancer claims
A Missouri judge approved a $7.25 billion settlement Friday between agrochemical maker Bayer and thousands of U.S. cancer patients who claim the company's Roundup weedkiller caused lymphoma without proper warning, according to WPLG Local 10 and WKMG News 6.
The settlement will be paid over two decades and covers both people already diagnosed with non-Hodgkin lymphoma and those who may be diagnosed in the future. Participants could receive an average of between $10,000 and $165,000, depending on how they used the product, their age at diagnosis and illness severity.
Bayer denies that Roundup causes cancer but agreed to the settlement to gain financial certainty against mounting litigation costs. The company has already changed the formula for Roundup sold to residential users. A St. Louis Circuit judge said the average payouts are "fair and adequate" and called the total settlement amount "among the largest in the history of mass tort personal-injury class action settlements."
The settlement came after the U.S. Supreme Court ruled in June that Bayer cannot be sued in state courts over failure-to-warn claims, since federal regulations do not require a cancer warning label and states cannot impose additional labeling requirements. Some attorneys for cancer patients said the payouts are too small, while others argued the deal was better than the uncertain outcome they faced after the Supreme Court ruling.
Sources
- WPLG Local 10: Court approves $7.25 billion settlement with Bayer over claims Roundup weedkiller caused cancer
- WKMG News 6 ClickOrlando: Court approves $7.25 billion settlement with Bayer over claims Roundup weedkiller caused cancer
